As companies embark on the path to recovery, M&A is poised to have an outsized influence in shaping the “next normal.” But in the aftermath of COVID-19, it is inevitable that deal making will materially change to reflect the new priorities of a post-crisis world.
Read the full insight on the Deloitte website